Rhythm Pharmaceuticals clinical trials we track

Check company identity source

Phase 3 8 trials

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
Long Term Extension Trial of SetmelanotideNCT03651765SetmelanotideCompleted2025-01-09Actual

Phase 2 8 trials

Phase 1 / 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway ImpairmentNCT06239116Part C: RM-718, Part D: RM-718Active not recruiting2027-05-07Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Difference in mean change in body weight in patients treated with setmelanotide compared to placebo, assessed as percent change in BMI Time frame: Baseline to 52 weeks. After: Measure: Treatment Period: Percent Change From Baseline in Body Mass Index (BMI) Description: BMI was calculated using participant's weight and height assessments as weight in kilograms (kg)/(height in meters \[m\])\^2. Baseline was defined as the last available measurement taken prior to the start of treatment administration. An analysis of covariance (ANCOVA) model was used to calculate the least-squares mean with randomization stratification factors and baseline value as a covariate. Time frame: Baseline, Week 52.

Primary completion date changed

Before: 22 Dec 2025. After: 19 Dec 2025.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Mean percentage change in BMI Time frame: From Baseline to Week 14. After: Measure: Treatment Phase: Mean Percentage Change From Baseline to Week 14 in Body Mass Index (BMI) Description: BMI was calculated as weight (kilograms \[kg\])/height (squared meters \[m\^2\]). Least square mean (LSM) and standard error (SE) were calculated using analysis of covariance (ANCOVA) model with treatment group, randomization stratification factor (≥18 years old vs \<18 years old) as factors and baseline BMI as a covariate. Time frame: Baseline, Week 14.

Check registry source
Open-Label Extension Study of Setmelanotide

NCT06596135 · Rhythm Pharmaceuticals, Inc.

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 30 participants (planned). After: 28 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Oct 2027. After: 24 Jun 2026.

Recruitment status changed

Before: Enrolling by invitation. After: Completed.

Check registry source
A Trial of Setmelanotide in Acquired Hypothalamic Obesity

NCT05774756 · Rhythm Pharmaceuticals, Inc.

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Mean % change in BMI. After: Measure: Pivotal Cohort: Mean Percent Change From Baseline in Body Mass Index (BMI) After 52 Weeks on a Therapeutic Regimen.

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 120 participants (planned). After: 143 participants (actual).

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Jan 2026. After: 9 Feb 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source
A Study of Setmelanotide in Patients With Prader-Willi Syndrome

NCT06772597 · Rhythm Pharmaceuticals, Inc.

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 20 participants (planned). After: 18 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 400 participants (planned). After: 296 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2025. After: 22 Dec 2025.

Check registry source